Contributor:

Incorporating iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR & Interventional Glaucoma

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Outcomes

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Success

Savak “Sev” Teymoorian, MD, MBA

iDose TR Patient Selection

Savak “Sev” Teymoorian, MD, MBA

iDose TR: Day of Procedure

Savak “Sev” Teymoorian, MD, MBA

Patient Education for iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR: An Interventional Mindset

Savak “Sev” Teymoorian, MD, MBA

Patient Identification for iDose TR®

Savak Teymoorian, MD, MBA; John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; and Lorraine M. Provencher, MD

Collaborative Care in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Expert Panel iDose TR® Q&A Session

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

The Future of Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

What Does It Mean to Be Interventional?

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Live Demonstration: iDose TR® Implantation

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

iDose TR® Live Procedure Broadcast

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

Achieving Success in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Making Patients Comfortable With iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR: A Patient’s Perspective

Savak “Sev” Teymoorian, MD, MBA

The Algorithm: Choosing the Appropriate Glaucoma Treatment

I. Paul Singh, MD; J. David Stephens, MD; and Savak Teymoorian, MD, MBA